Finance

Lists
601089:SHA
Beijing Foyou Pharma Co Ltd
CNÂ¥16.44
+0.98%
(+0.16) 1D
Aug 26, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 601089...
Open
CNÂ¥16.28
High
CNÂ¥16.68
Low
CNÂ¥16.21
Mkt. cap
7.68B
Avg. vol.
5.30M
Volume
3.02M
Dividend
3.04%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Jun 2, 2026
P/E ratio
19.85
52-wk high
CNÂ¥30.80
52-wk low
CNÂ¥15.28
EPS
CNÂ¥0.83
No. of employees
4K
Open
CNÂ¥16.28
High
CNÂ¥16.68
Low
CNÂ¥16.21
Mkt. cap
7.68B
Avg. vol.
5.30M
Volume
3.02M
Dividend
3.04%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Jun 2, 2026
P/E ratio
19.85
52-wk high
CNÂ¥30.80
52-wk low
CNÂ¥15.28
EPS
CNÂ¥0.83
No. of employees
4K
About Beijing Foyou Pharma Co Ltd
CEO-
Employees3.91K
FoundedFeb 3, 1999
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
886.63M
983.84M
811.17M
898.98M
Cost of goods sold
306.52M
366.92M
310.71M
370.31M
Cost of revenue
306.52M
366.92M
310.71M
370.31M
Research and development expenses
111.15M
126.58M
97.86M
107.26M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
343.96M
388.17M
301.77M
324.45M
Operating expense
458.31M
531.85M
399.87M
436.58M
Total operating expenses
764.83M
898.77M
710.59M
806.89M
Operating income
121.81M
85.07M
100.58M
92.09M
Other non operating income
-4.25M
4.38M
-127.61K
2.21M
EBT including unusual items
116.35M
105.48M
104.06M
96.77M
EBT excluding unusual items
120.24M
98.86M
105.83M
100.30M
Income tax expense
7.03M
12.01M
7.86M
5.26M
Effective tax rate
6.04%
11.38%
7.55%
5.44%
Other operating expenses
2.47M
14.99M
2.01M
3.11M
Net income
107.47M
94.02M
95.41M
90.78M
Net profit margin
12.12%
9.56%
11.76%
10.10%
Earnings per share
-
-
-
-
Interest and investment income
3.13M
9.82M
5.63M
6.00M
Interest expense
-330.34K
-310.23K
-246.71K
-
Net interest expenses
2.80M
9.51M
5.38M
6.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
142.70M
113.10M
128.61M
127.26M
Gain or loss from assets sale
-35.00K
-21.84K
-
-803.25K
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps